日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer

CCK受体种系突变：胰腺癌的一种新型生物标志物

期刊:Clinical and Translational Gastroenterology
影响因子:3
doi:10.1038/ctg.2015.61
Alsubai, Jelal; Matters, Gail L; McGovern, Christopher O; Liao, Jiangang; Gilius, Evan L; Smith, Jill P
信号转导
胰腺癌
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate

光免疫纳米疗法揭示鞘氨醇激酶2和二氢鞘氨醇-1-磷酸酯的抗癌作用

期刊:ACS Nano
影响因子:16
doi:10.1021/nn304862b
Barth, Brian M; Shanmugavelandy, Sriram S; Kaiser, James M; McGovern, Christopher; Altınoğlu, Erhan İ; Haakenson, Jeremy K; Hengst, Jeremy A; Gilius, Evan L; Knupp, Sarah A; Fox, Todd E; Smith, Jill P; Ritty, Timothy M; Adair, James H; Kester, Mark
信号转导
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2013
文献求助 收藏

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.

胆囊收缩素 B 受体的单核苷酸多态性可预测胰腺癌的风险

期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.4161/cbt.13.3.18698
Smith Jill P, Harms John F, Matters Gail L, McGovern Christopher O, Ruggiero Francesca M, Liao Jiangang, Fino Kristin K, Ortega Emily E, Gilius Evan L, Phillips John A 3rd
肿瘤
胰腺癌
发表日期：2012
文献求助 收藏